Need to define a subgroup of patients with idiopathic mast cell activation syndrome.
Theoharis C Theoharides discusses the necessity of identifying and defining a specific subgroup of patients diagnosed with idiopathic Mast Cell Activation Syndrome (MCAS). The resource likely explores the challenges in diagnosing MCAS due to its varied presentation and the importance of establishing clearer diagnostic criteria to improve patient identification and treatment strategies.
Published April 11, 2022
